Braidwell’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-498,000
Closed -$28.5M 80
2025
Q3
$28.5M Buy
498,000
+250,800
+101% +$14.4M 0.85% 36
2025
Q2
$14.6M Buy
+247,200
New +$16M 0.5% 46
2023
Q2
Sell
-335,200
Closed -$19M 86
2023
Q1
$19M Sell
335,200
-8,426
-2% -$540K 0.63% 54
2022
Q4
$25.5M Buy
+343,626
New +$23.4M 0.86% 46

Other funds holding GMED

Braidwell's GMED Position: Q4 2025 in Review

Braidwell sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 498,000 shares — an estimated $28.5M sold.

Braidwell first reported a position in GMED in Q4 2022 and held it in 4 quarters. The position peaked at $28.5M in Q3 2025. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Braidwell reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Braidwell sold 498,000 Globus Medical shares in Q4 2025, an estimated $28.5M.
  • Braidwell first reported a position in Globus Medical in Q4 2022 and held it in 4 quarters.
  • Braidwell's Globus Medical position peaked at $28.5M in Q3 2025.
  • 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Braidwell's 13F filing for Q4 2025, filed 17 Feb 2026.